Evolent Health, Inc. (NYSE ... Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and exclusive insights on EVH. Our Pro platform offers fair value estimates ...

Founders know the mantra: make data-driven decisions. In recent years, the scientific approach to nurturing start-ups—developing hypotheses, collecting evidence that either supports or refutes ...

Enter: my five go-to prompts that guide me when I feel unsure about how to make a decision. Using decision-making frameworks and tools has helped me manage stress, feel less rushed, and stay more ...

ARLINGTON, Va. (AP) — ARLINGTON, Va. (AP) — Evolent Health Inc. (EVH) on Thursday reported a loss of $22.8 million in its fourth quarter. The Arlington, Virginia-based company said it had a ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of $18.00. The company’s shares closed yesterday at $10.71.

Dedicated employee costs primarily include project management and technology staff costs needed to migrate acquired businesses to Evolent's integrated technology platform and costs related to the ...

CEO Seth Blackley noted Evolent Health achieved $2.55 billion in revenue for 2024, reflecting a 30% growth over the prior year, and $160.5 million in adjusted EBITDA at the low end of the guidance ...

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago. These figures are ...

NEW YORK - Evolent Health, Inc. (NYSE:EVH) reported fourth-quarter results that fell short of analyst expectations and provided lower-than-anticipated guidance for 2025, sending shares down 2% in ...